Biologics do not increase the risk of second malignancy in rheumatoid arthritis patients

(American College of Rheumatology) Treatment with biologics does not increase the risk of a second malignancy in rheumatoid arthritis patients who have a history of cancer, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting.